Log in to save to my catalogue

Mirtazapine for agitation in dementia: moving forward

Mirtazapine for agitation in dementia: moving forward

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2585917991

Mirtazapine for agitation in dementia: moving forward

About this item

Full title

Mirtazapine for agitation in dementia: moving forward

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2021-10, Vol.398 (10310), p.1462-1463

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Over the past decade, efforts have included trials using citalopram,4 dextromethorphan,5 brexpiprazole,6 and nabilone.7 In The Lancet, Sube Banerjee and colleagues present data from the Study of Mirtazapine for Agitated Behaviours in Dementia (SYMBAD), which is a randomised, double-blind, placebo-controlled trial done at 26 UK sites.8 Mirtazapine w...

Alternative Titles

Full title

Mirtazapine for agitation in dementia: moving forward

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2585917991

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2585917991

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(21)01421-5

How to access this item